Nathalie Rioux

3.2k total citations
37 papers, 1.1k citations indexed

About

Nathalie Rioux is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Nathalie Rioux has authored 37 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 10 papers in Pharmacology and 9 papers in Oncology. Recurrent topics in Nathalie Rioux's work include Pharmacogenetics and Drug Metabolism (10 papers), Epigenetics and DNA Methylation (8 papers) and Inflammatory mediators and NSAID effects (7 papers). Nathalie Rioux is often cited by papers focused on Pharmacogenetics and Drug Metabolism (10 papers), Epigenetics and DNA Methylation (8 papers) and Inflammatory mediators and NSAID effects (7 papers). Nathalie Rioux collaborates with scholars based in Canada, United States and France. Nathalie Rioux's co-authors include André Castonguay, Nigel J. Waters, Richard Chesworth, Robert A. Copeland, Mikel P. Moyer, J. Joshua Smith, Guylaine Jalbert, Margaret Porter Scott, Lei Jin and P. Ann Boriack‐Sjodin and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Nathalie Rioux

34 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nathalie Rioux Canada 15 566 274 184 157 157 37 1.1k
Jennie L. Williams United States 21 475 0.8× 411 1.5× 160 0.9× 262 1.7× 232 1.5× 40 1.2k
Heather N. Tinsley United States 18 775 1.4× 361 1.3× 115 0.6× 113 0.7× 168 1.1× 36 1.3k
Linda C. Hsi United States 21 628 1.1× 478 1.7× 189 1.0× 266 1.7× 154 1.0× 32 1.4k
Adam B. Keeton United States 25 1.1k 2.0× 368 1.3× 155 0.8× 166 1.1× 349 2.2× 84 1.8k
Hsin-Hsiung Tai United States 18 530 0.9× 804 2.9× 295 1.6× 303 1.9× 238 1.5× 25 1.4k
Xavier de Leval Belgium 25 415 0.7× 557 2.0× 139 0.8× 82 0.5× 143 0.9× 46 1.4k
Pascal Grondin France 14 1.4k 2.4× 270 1.0× 53 0.3× 140 0.9× 89 0.6× 16 2.1k
Edgar S. Díaz‐Cruz United States 17 356 0.6× 215 0.8× 528 2.9× 143 0.9× 268 1.7× 30 1.1k
N S Paranka United States 8 334 0.6× 766 2.8× 425 2.3× 211 1.3× 253 1.6× 10 1.1k
Michael A. Shirley United States 15 684 1.2× 102 0.4× 241 1.3× 64 0.4× 204 1.3× 22 1.1k

Countries citing papers authored by Nathalie Rioux

Since Specialization
Citations

This map shows the geographic impact of Nathalie Rioux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathalie Rioux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathalie Rioux more than expected).

Fields of papers citing papers by Nathalie Rioux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathalie Rioux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathalie Rioux. The network helps show where Nathalie Rioux may publish in the future.

Co-authorship network of co-authors of Nathalie Rioux

This figure shows the co-authorship network connecting the top 25 collaborators of Nathalie Rioux. A scholar is included among the top collaborators of Nathalie Rioux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathalie Rioux. Nathalie Rioux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yang, Ziping, Nathalie Rioux, Hannah M. Jones, et al.. (2023). A comprehensive evaluation in clinic and physiologically‐based pharmacokinetic modeling and simulation to confirm lack of cytochrome P450–mediated drug–drug interaction potential for pomotrelvir. CPT Pharmacometrics & Systems Pharmacology. 12(10). 1553–1564. 3 indexed citations
3.
Rioux, Nathalie, Sherri Smith, Manav Korpal, et al.. (2018). Nonclinical pharmacokinetics and in vitro metabolism of H3B-6545, a novel selective ERα covalent antagonist (SERCA). Cancer Chemotherapy and Pharmacology. 83(1). 151–160. 14 indexed citations
4.
Rioux, Nathalie, Amy Kim, Darrell Nix, et al.. (2018). Effect of a high-fat meal on the relative bioavailability of H3B-6527, a novel FGFR4 inhibitor, in healthy volunteers. Cancer Chemotherapy and Pharmacology. 83(1). 91–96. 3 indexed citations
5.
Rioux, Nathalie & Nigel J. Waters. (2016). Physiologically Based Pharmacokinetic Modeling in Pediatric Oncology Drug Development. Drug Metabolism and Disposition. 44(7). 934–943. 24 indexed citations
6.
Mitchell, Lorna H., Allison E. Drew, Scott Ribich, et al.. (2015). Aryl Pyrazoles as Potent Inhibitors of Arginine Methyltransferases: Identification of the First PRMT6 Tool Compound. ACS Medicinal Chemistry Letters. 6(6). 655–659. 95 indexed citations
7.
Campbell, John E., Kevin W. Kuntz, Sarah K. Knutson, et al.. (2015). EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust in Vivo Activity. ACS Medicinal Chemistry Letters. 6(5). 491–495. 94 indexed citations
8.
Duncan, Kenneth W., Nathalie Rioux, P. Ann Boriack‐Sjodin, et al.. (2015). Structure and Property Guided Design in the Identification of PRMT5 Tool Compound EPZ015666. ACS Medicinal Chemistry Letters. 7(2). 162–166. 103 indexed citations
9.
Rioux, Nathalie, Kenneth W. Duncan, Xiu‐Sheng Miao, et al.. (2015). Species differences in metabolism of EPZ015666, an oxetane-containing protein arginine methyltransferase-5 (PRMT5) inhibitor. Xenobiotica. 46(3). 268–277. 16 indexed citations
10.
Rioux, Nathalie, Lorna H. Mitchell, Philip R. Tiller, et al.. (2015). Structural and Kinetic Characterization of a Novel N-acetylated Aliphatic Amine Metabolite of the PRMT Inhibitor, EPZ011652. Drug Metabolism and Disposition. 43(7). 936–943. 5 indexed citations
11.
Messai, Yosra, Meriem Hasmim, Nathalie Rioux, et al.. (2014). Tumoral CD105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinoma. British Journal of Cancer. 110(7). 1778–1784. 52 indexed citations
12.
Rioux, Nathalie, et al.. (2013). A strategy to reduce biliary clearance in early drug discovery. Journal of Pharmacological and Toxicological Methods. 68(3). 346–348. 1 indexed citations
13.
Rioux, Nathalie, et al.. (2013). A membrane vesicle-based assay to enable prediction of human biliary excretion. Xenobiotica. 43(10). 915–919. 7 indexed citations
14.
Rioux, Nathalie, et al.. (2012). A simplified approach to predict CYP3A-mediated drug–drug interactions at early drug discovery: validation with clinical data. Xenobiotica. 43(7). 592–597. 4 indexed citations
15.
Taflin, Cécile, Dominique Nochy, Gary S. Hill, et al.. (2010). Regulatory T Cells in Kidney Allograft Infiltrates Correlate With Initial Inflammation and Graft Function. Transplantation. 89(2). 194–199. 49 indexed citations
16.
Caron, Étienne, et al.. (2006). Quantification of the expression and inducibility of 12 rat cytochrome P450 isoforms by quantitative RT–PCR. Journal of Biochemical and Molecular Toxicology. 19(6). 368–378. 34 indexed citations
17.
Rioux, Nathalie & André Castonguay. (2001). 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone modulation of cytokine release in U937 human macrophages. Cancer Immunology Immunotherapy. 49(12). 663–670. 17 indexed citations
18.
Rioux, Nathalie & André Castonguay. (1999). Induction of COX expression by a tobacco carcinogen: Implication in lung cancer chemoprevention. Inflammation Research. 48(0). 136–137. 7 indexed citations
19.
Rioux, Nathalie. (1998). Inhibitors of lipoxygenase: a new class of cancer chemopreventive agents. Carcinogenesis. 19(8). 1393–1400. 170 indexed citations
20.
Rioux, Nathalie, André Castonguay, & D. Hoffmann. (1997). Recovery From 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone-Induced Immunosuppression in A/J Mice by Treatment With Nonsteroidal Antiinflammatory Drugs. JNCI Journal of the National Cancer Institute. 89(12). 874–880. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennie L. Williams Breakdown of academic impact, for papers by Heather N. Tinsley Breakdown of academic impact, for papers by Linda C. Hsi Breakdown of academic impact, for papers by Adam B. Keeton Breakdown of academic impact, for papers by Hsin-Hsiung Tai Breakdown of academic impact, for papers by Xavier de Leval Breakdown of academic impact, for papers by Pascal Grondin Breakdown of academic impact, for papers by Edgar S. Díaz‐Cruz Breakdown of academic impact, for papers by N S Paranka Breakdown of academic impact, for papers by Michael A. Shirley
Rankless by CCL
2026